PCM
JNCE

Penserra Capital Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Penserra Capital Management’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,170
Closed -$8K – 1612
2021
Q3 		$8K Buy
1,170
+5
+0.4% +$34 ﹤0.01% 1387
2021
Q2 		$7K Buy
1,165
+135
+13% +$811 ﹤0.01% 1305
2021
Q1 		$10K Buy
1,030
+85
+9% +$825 ﹤0.01% 1043
2020
Q4 		$6K Buy
+945
New +$6K ﹤0.01% 980